Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-16

Clinical Trial Update: [68]GA-FAPI-46 PET/CT for the Diagnosis of Metastatic Lesions in Patients With Lobular Breast Cancer (ICL). [NA]

View source ↗

Summary

A clinical trial evaluating GA-FAPI-46 PET/CT for identifying metastatic lesions in invasive lobular carcinoma of the breast; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GA-FAPI-46 PET/CT (GA-FAPI-46 radiotracer)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Lobular Carcinoma, Breast Cancer | NA | Status: NOT_YET_RECRUITING